The University of Southampton
University of Southampton Institutional Repository

Interactions between anticholinesterases in an in vitro central nervous system preparation

Interactions between anticholinesterases in an in vitro central nervous system preparation
Interactions between anticholinesterases in an in vitro central nervous system preparation
Organophosphate compounds have been widely developed as pesticides (e.g. paraoxon) and also as chemical warfare agents (nerve agents, e.g. sarin). These compounds rapidly inhibit the enzyme acetylcholinesterase (AChE), causing overstimulation within the cholinergic nervous system. If left untreated, this can be fatal. Current medical countermeasures to nerve agent poisoning consist of pretreatment with pyridostigmine and an emergency therapy comprising atropine, diazepam and pralidoxime. As well as a replacement pretreatment for pyridostigmine, physostigmine has been proposed as a component of a next generation of therapy to nerve agent poisoning, along with scopolamine and HI6. In animal studies, this therapy has been shown to lessen the level of incapacitation and increase survivability post poisoning with nerve agent. The exact mechanism of action of physostigmine in this combination is as yet unclear.
The primary aim of this study was to test the hypothesis that the beneficial effect of physostigmine in the proposed therapy is due to reversible inhibition of AChE, thereby protecting it from irreversible inhibition by nerve agent. To test this, extracellular field potentials were recorded from the molecular layer of the dentate gyrus in an in vitro slice model developed from the guinea pig. This response was shown to be modulated by the application of physostigmine and the nerve agent sarin and interactions between the two inhibitors were characterised. The results provided evidence for protection of ChE by physostigmine. The functional response (field potential) was related to cholinesterase activity measured in slices exposed to sarin.
This is the first evidence of the mechanism of action of physostigmine protection against nerve agent in the CNS. Not only will these results support the use of physostigmine as a pre-treatment, it also supports its use as a possible immediate therapy.
Scott, Iain Ratcliffe
2891cc93-4658-4615-a86c-fe744d8075f2
Scott, Iain Ratcliffe
2891cc93-4658-4615-a86c-fe744d8075f2
Pringle, Ashley
6339ed95-c491-43a8-b2fb-2384466dc80d
Sundstrom, L
370d5aa7-aec4-417a-b813-b27936dd2d69
Tatterstall, J
eb1ed5f8-59bf-49d8-8460-29a28b45605c

Scott, Iain Ratcliffe (2008) Interactions between anticholinesterases in an in vitro central nervous system preparation. University of Southampton, School of Medicine, Doctoral Thesis, 187pp.

Record type: Thesis (Doctoral)

Abstract

Organophosphate compounds have been widely developed as pesticides (e.g. paraoxon) and also as chemical warfare agents (nerve agents, e.g. sarin). These compounds rapidly inhibit the enzyme acetylcholinesterase (AChE), causing overstimulation within the cholinergic nervous system. If left untreated, this can be fatal. Current medical countermeasures to nerve agent poisoning consist of pretreatment with pyridostigmine and an emergency therapy comprising atropine, diazepam and pralidoxime. As well as a replacement pretreatment for pyridostigmine, physostigmine has been proposed as a component of a next generation of therapy to nerve agent poisoning, along with scopolamine and HI6. In animal studies, this therapy has been shown to lessen the level of incapacitation and increase survivability post poisoning with nerve agent. The exact mechanism of action of physostigmine in this combination is as yet unclear.
The primary aim of this study was to test the hypothesis that the beneficial effect of physostigmine in the proposed therapy is due to reversible inhibition of AChE, thereby protecting it from irreversible inhibition by nerve agent. To test this, extracellular field potentials were recorded from the molecular layer of the dentate gyrus in an in vitro slice model developed from the guinea pig. This response was shown to be modulated by the application of physostigmine and the nerve agent sarin and interactions between the two inhibitors were characterised. The results provided evidence for protection of ChE by physostigmine. The functional response (field potential) was related to cholinesterase activity measured in slices exposed to sarin.
This is the first evidence of the mechanism of action of physostigmine protection against nerve agent in the CNS. Not only will these results support the use of physostigmine as a pre-treatment, it also supports its use as a possible immediate therapy.

Text
Iain_Scott_Final_PhD_Thesis_2008.pdf - Other
Download (2MB)

More information

Published date: December 2008
Organisations: University of Southampton

Identifiers

Local EPrints ID: 72908
URI: http://eprints.soton.ac.uk/id/eprint/72908
PURE UUID: 713709bd-aadd-460a-91f9-1dd6825109a4
ORCID for Ashley Pringle: ORCID iD orcid.org/0000-0003-2421-4380

Catalogue record

Date deposited: 16 Mar 2010
Last modified: 14 Mar 2024 02:38

Export record

Contributors

Author: Iain Ratcliffe Scott
Thesis advisor: Ashley Pringle ORCID iD
Thesis advisor: L Sundstrom
Thesis advisor: J Tatterstall

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×